540 related articles for article (PubMed ID: 17198774)
1. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
[TBL] [Abstract][Full Text] [Related]
3. Biochemical assessment of myocardial injury after cardiac surgery: effects of a platelet activating factor antagonist, bilateral internal thoracic artery grafts, and coronary endarterectomy.
Taggart DP
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):651-9. PubMed ID: 11003744
[TBL] [Abstract][Full Text] [Related]
4. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
[TBL] [Abstract][Full Text] [Related]
6. The effects of low dose N-acetylcysteine (NAC) as an adjunct to cardioplegia in coronary artery bypass surgery.
Köksal H; Rahman A; Burma O; Halifeoğlu I; Bayar MK
Anadolu Kardiyol Derg; 2008 Dec; 8(6):437-43. PubMed ID: 19103540
[TBL] [Abstract][Full Text] [Related]
7. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
[TBL] [Abstract][Full Text] [Related]
8. Myocardial enzyme release in totally endoscopic coronary artery bypass grafting on the arrested heart.
Schachner T; Bonaros N; Ruetzler E; Weidinger F; Oehlinger A; Laufer G; Friedrich G; Bonatti J
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):1006-11. PubMed ID: 17903521
[TBL] [Abstract][Full Text] [Related]
9. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: a randomized, double-blind study.
Roth M; Kraus B; Scheffold T; Reuthebuch O; Klövekorn WP; Bauer EP
J Thorac Cardiovasc Surg; 2000 Oct; 120(4):642-50. PubMed ID: 11003743
[TBL] [Abstract][Full Text] [Related]
10. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass.
Shernan SK; Fitch JC; Nussmeier NA; Chen JC; Rollins SA; Mojcik CF; Malloy KJ; Todaro TG; Filloon T; Boyce SW; Gangahar DM; Goldberg M; Saidman LJ; Mangano DT;
Ann Thorac Surg; 2004 Mar; 77(3):942-9; discussion 949-50. PubMed ID: 14992903
[TBL] [Abstract][Full Text] [Related]
11. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
Andreasen JJ; Nielsen C
Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
[TBL] [Abstract][Full Text] [Related]
13. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E
Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting.
Koramaz I; Pulathan Z; Usta S; Karahan SC; Alver A; Yaris E; Kalyoncu NI; Ozcan F
Ann Thorac Surg; 2006 Feb; 81(2):613-8. PubMed ID: 16427861
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
[TBL] [Abstract][Full Text] [Related]
16. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery.
Fischer UM; Tossios P; Huebner A; Geissler HJ; Bloch W; Mehlhorn U
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):103-8. PubMed ID: 15224028
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic intravenous magnesium sulphate in addition to oral {beta}-blockade does not prevent atrial arrhythmias after coronary artery or valvular heart surgery: a randomized, controlled trial.
Cook RC; Humphries KH; Gin K; Janusz MT; Slavik RS; Bernstein V; Tholin M; Lee MK
Circulation; 2009 Sep; 120(11 Suppl):S163-9. PubMed ID: 19752363
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
19. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
Mannacio VA; Iorio D; De Amicis V; Di Lello F; Musumeci F
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1541-8. PubMed ID: 19114204
[TBL] [Abstract][Full Text] [Related]
20. Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
Budeus M; Hennersdorf M; Perings S; Röhlen S; Schnitzler S; Felix O; Reimert K; Feindt P; Gams E; Lehmann N; Wieneke H; Sack S; Erbel R; Perings C
Eur Heart J; 2006 Jul; 27(13):1584-91. PubMed ID: 16760210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
